Intense Androgen-Deprivation Therapy With Abiraterone Acetate Plus Leuprolide Acetate in Patients With Localized High-Risk Prostate Cancer: Results of a Randomized Phase II Neoadjuvant Study

PURPOSE: Cure rates for localized high-risk prostate cancers (PCa) and some intermediate-risk PCa are frequently suboptimal with local therapy. Outcomes are improved by concomitant androgen-deprivation therapy (ADT) with radiation therapy, but not by concomitant ADT with surgery. Luteinizing hormone...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Taplin, Mary-Ellen, Montgomery, Bruce, Logothetis, Christopher J., Bubley, Glenn J., Richie, Jerome P., Dalkin, Bruce L., Sanda, Martin G., Davis, John W., Loda, Massimo, True, Lawrence D., Troncoso, Patricia, Ye, Huihui, Lis, Rosina T., Marck, Brett T., Matsumoto, Alvin M., Balk, Steven P., Mostaghel, Elahe A., Penning, Trevor M., Nelson, Peter S., Xie, Wanling, Jiang, Zhenyang, Haqq, Christopher M., Tamae, Daniel, Tran, NamPhuong, Peng, Weimin, Kheoh, Thian, Molina, Arturo, Kantoff, Philip W.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2014
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4226804/
https://ncbi.nlm.nih.gov/pubmed/25311217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.53.4578
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares